- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Cytokeratin 4 Antibody KRT4/2804 recognizes keratin 4 (KRT4), a type II intermediate filament protein expressed predominantly in the suprabasal layers of non-keratinized stratified squamous epithelia. Also known as CK4 or cytokeratin 4, this approximately 59 kDa protein is encoded by the KRT4 gene on chromosome 12. KRT4 contributes to the structural integrity of epithelial cells by forming cytoplasmic intermediate filament networks that provide mechanical stability. Its expression is particularly prominent in the esophagus, oral mucosa, pharynx, and other mucosal surfaces exposed to repeated mechanical stress.
KRT4 typically forms heterodimers with keratin 13 (KRT13), a type I intermediate filament protein expressed in similar epithelial compartments. These heterodimers assemble into higher-order filament structures that help maintain cell shape and epithelial resilience. During squamous epithelial differentiation, KRT4 and KRT13 expression increases as cells move away from the proliferative basal layer. Their coordinated expression distinguishes many non-keratinized stratified epithelia from keratinized tissues, where proteins such as KRT1 and KRT10 are more characteristic. KRT4 is therefore useful for investigating epithelial differentiation and tissue-specific keratin expression.
Mutations in KRT4 are associated with white sponge nevus, a rare inherited disorder characterized by thickened, white, folded plaques affecting the oral mucosa and occasionally other mucosal surfaces. Disease-associated variants can disrupt intermediate filament organization and alter epithelial differentiation. KRT4 expression is also investigated in squamous cell carcinoma, particularly tumors originating from the upper aerodigestive tract. Reduced expression has been reported in some head and neck squamous carcinomas, although keratin profiles vary with tumor differentiation and anatomical origin.
Changes in KRT4 expression may provide information about epithelial remodeling, mucosal injury, and malignant transformation. The protein is studied alongside other keratins to characterize epithelial identity and differentiation status. NSJ Bioreagents offers mouse monoclonal clone KRT4/2804, developed against recombinant human KRT4 amino acids 181-292 and supported by immunofluorescence, immunohistochemistry, flow cytometry, and protein microarray validation. A Cytokeratin 4 Antibody provides a useful reagent for investigating mucosal epithelial differentiation, intermediate filament organization, and squamous epithelial biology.
Explore our Cytokeratin 4 Antibodies for investigating mucosal epithelial differentiation, keratin filament organization, and KRT4 expression in normal and diseased tissues.
Optimal dilution of the Cytokeratin 4 Antibody KRT4/2804 / CK4 Monoclonal Antibody should be determined by the researcher.
A recombinant human partial protein (amino acids 181-292) was used as the immunogen for this Cytokeratin 4 Antibody KRT4/2804.
Store the Cytokeratin 4 Antibody KRT4/2804 at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
KRT4 antibody, Keratin 4 antibody, CK4 antibody, Cytokeratin-4 antibody, Keratin Type II Cytoskeletal 4 antibody, Keratin-4 antibody, Cytokeratin IV antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.